EF
Empirical Finance’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $221K | Buy |
1,454
+12
| +0.8% | +$1.82K | 0.01% | 499 |
|
2025
Q1 | $217K | Buy |
1,442
+133
| +10% | +$20K | 0.01% | 494 |
|
2024
Q4 | $242K | Sell |
1,309
-1
| -0.1% | -$185 | 0.01% | 486 |
|
2024
Q3 | $258K | Buy |
1,310
+53
| +4% | +$10.4K | 0.02% | 489 |
|
2024
Q2 | $260K | Sell |
1,257
-15
| -1% | -$3.1K | 0.02% | 481 |
|
2024
Q1 | $345K | Buy |
1,272
+64
| +5% | +$17.3K | 0.02% | 474 |
|
2023
Q4 | $286K | Buy |
1,208
+29
| +2% | +$6.86K | 0.02% | 488 |
|
2023
Q3 | $231K | Buy |
1,179
+188
| +19% | +$36.8K | 0.02% | 502 |
|
2023
Q2 | $208K | Buy |
+991
| New | +$208K | 0.02% | 502 |
|